Davide Bedognetti
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 75
- Cancer Immunotherapy and Biomarkers 49
- CAR-T cell therapy research 19
- Immunology 56
- Immunotherapy and Immune Responses 31
- Immune Cell Function and Interaction 15
- Immune cells in cancer 11
- Co-authors
- Francesco M. MarincolaJérôme GalonHelen K. AngellLucia Gemma DeloguWouter HendrickxEna WangJessica RoelandsAlberto Bianco
- Journals
- Journal of Translational Medicine (18 papers)Journal for ImmunoTherapy of Cancer (9 papers)British Journal of Cancer (6 papers)Frontiers in Immunology (5 papers)OncoImmunology (5 papers)
- Partner nations
- United StatesQatarItaly
In The Last Decade
Davide Bedognetti
128 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 2.7k
- Immunology 2.0k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 933
- Molecular Biology 1.9k
Countries citing papers authored by Davide Bedognetti
This map shows the geographic impact of Davide Bedognetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Bedognetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Bedognetti more than expected).
Fields of papers citing papers by Davide Bedognetti
This network shows the impact of papers produced by Davide Bedognetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Bedognetti. The network helps show where Davide Bedognetti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Davide Bedognetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 22 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 25 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 31 | |
| 15 | Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic Hit paper breakdown → | 2020 | 451 |
| 16 | 2017 | 105 | |
| 17 | 2017 | 128 | |
| 18 | 2016 | 76 | |
| 19 | 2015 | 48 | |
| 20 | 2010 | 44 |
About Davide Bedognetti
Davide Bedognetti is a scholar working on Oncology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 134 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (49 papers), Immunotherapy and Immune Responses (31 papers), Cancer Genomics and Diagnostics (22 papers), CAR-T cell therapy research (19 papers), Ferroptosis and cancer prognosis (16 papers), Immune Cell Function and Interaction (15 papers), Graphene and Nanomaterials Applications (11 papers) and Immune cells in cancer (11 papers). The work is most often cited by research in Oncology (2.7k citations), Immunology (2.0k citations), Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (933 citations) and Molecular Biology (1.9k citations). Davide Bedognetti has collaborated with scholars based in United States, Qatar and Italy. Frequent co-authors include Francesco M. Marincola, Jérôme Galon, Francesco M. Marincola, Helen K. Angell, Lucia Gemma Delogu, Wouter Hendrickx, Ena Wang, Jessica Roelands, Alberto Bianco and Julie Decock. Their work appears in journals such as Journal of Translational Medicine, Journal for ImmunoTherapy of Cancer, British Journal of Cancer, Frontiers in Immunology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.